Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combining treatment selection and definitive testing.

Michael A Proschan1, Sally A Hunsberger

  • 1Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, 6700A Rockledge Drive, Bethesda, MD, USA. proscham@niaid.nih.gov

Biometrical Journal. Biometrische Zeitschrift
|September 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.

Open forum infectious diseases·2026
Same author

Response-adaptive randomization with imperfect intermediate endpoints.

Clinical trials (London, England)·2026
Same author

Event-driven planning of two-armed trials with a binary endpoint.

Clinical trials (London, England)·2026
Same author

Futility Monitoring in Clinical Trials.

Statistics in medicine·2025
Same author

Does Remdesivir Lower COVID-19 Mortality? A Subgroup Analysis of Hospitalized Adults Receiving Supplemental Oxygen.

Statistics in medicine·2024
Same author

Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial.

Clinical trials (London, England)·2024
Same journal

Comparison of Different Methods for the Meta-Analysis of Diagnostic Test Accuracy Studies-A Simulation Study.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

When to Adjust for Multiple Testing: A Unifying Guiding Principle.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Ensuring Quality in Preclinical Research: The Importance of Being Human.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Addressing Cluster-Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

A Multiple Imputation Approach to Distinguish Curative From Life-Prolonging Effects in the Presence of Missing Covariates.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Tests for Categorical Data Beyond Pearson: A Distance Covariance and Energy Distance Approach.

Biometrical journal. Biometrische Zeitschrift·2026
See all related articles

This discussion covers adaptive trial designs for selecting treatments. It reviews two papers on hierarchical testing and conditional error functions for efficient and safe treatment selection.

Area of Science:

  • Clinical trial methodology
  • Biostatistics
  • Drug development

Background:

  • Adaptive trial designs allow for modifications during a study.
  • Selecting safe and effective treatments is crucial in clinical research.
  • Two key papers are discussed: one on adaptive hierarchical testing and another on a two-stage adaptive design.

Discussion:

  • The papers explore different statistical approaches to adaptive trial designs.
  • Both papers focus on optimizing treatment selection processes.
  • Key concepts include hierarchical testing and conditional error functions.

Key Insights:

  • Adaptive designs can enhance the efficiency and safety of treatment selection.
  • Hierarchical testing provides a structured approach to evaluating multiple treatments.

Related Experiment Videos

  • Conditional error functions offer flexibility in two-stage adaptive designs.

    • Outlook:

    • Further research into adaptive designs can improve clinical trial outcomes.
    • These methods hold promise for personalized medicine and faster drug development.
    • The integration of adaptive strategies is likely to increase in future clinical trials.